{"id":"CHEMBL1002","canonicalSmiles":"CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1","inchiKey":"NDAUXUAQIAJITI-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOSALBUTAMOL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASF-1096","Albuterol (r)-form","Levalbuterol","Levosalbutamol","R-salbutamol","Xopenex"],"crossReferences":{"DailyMed":["levalbuterol%20hydrochloride","levalbuterol%20tartrate"],"PubChem":["11111805","11111806","11112645","11113612"],"Wikipedia":["Levosalbutamol"],"drugbank":["DB13139"],"chEBI":["8746"]},"childChemblIds":["CHEMBL1201061","CHEMBL3989693","CHEMBL3989589"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0002153","MONDO_0004979","EFO_0000341","HP_0025428"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for asthma and has 3 investigational indications."}
{"id":"CHEMBL1086440","canonicalSmiles":"CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1","inchiKey":"NQPDXQQQCQDHHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLABENDAZOLE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Egaten","Egaten tm"],"synonyms":["EGA230B","Fasinex","NSC-759250","NVP-EGA230","Triclabendazole"],"crossReferences":{"DailyMed":["triclabendazole"],"PubChem":["144205784","26719864","26758032","49681760","50085431","85182180"],"Wikipedia":["Triclabendazole"],"drugbank":["DB12245"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for helminthiasis and fascioliasis."}
{"id":"CHEMBL1095032","canonicalSmiles":"O=C([C@H](O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1","inchiKey":"GEHAEMCVKDPMKO-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETAXABAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Letaxaban","TAK 442","TAK-442"],"crossReferences":{"drugbank":["DB11984"]},"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0004286","EFO_0005672"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1129","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F","inchiKey":"VSQQQLOSPVPRAZ-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLURIDINE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["T.f.t.","Trifluridine","Triherpine","Viroptic"],"synonyms":["F3dthd","NSC-529182","NSC-75520","Trifluridine","Trifluridine "],"crossReferences":{"DailyMed":["trifluridine"],"PubChem":["131404691","144205964","170464911","26748925","56422883","8139891"],"Wikipedia":["Trifluridine"],"drugbank":["DB00432"],"chEBI":["75179"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 8 approved and 6 investigational indications."}
{"id":"CHEMBL1162495","canonicalSmiles":"O=C(O)CCCC(=O)O","inchiKey":"JFCQEDHGNNZCLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTARATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glutarate"],"crossReferences":{"PubChem":["144209646","144213188"],"Wikipedia":["Glutaric_acid"],"drugbank":["DB03553"],"chEBI":["17859"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1186230","canonicalSmiles":"O=P(O)(O)[C@@H](NCc1ccccc1)c1ccccc1","inchiKey":"SLMGIUOAZCYKPE-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1186230","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03577"]},"childChemblIds":["CHEMBL454997"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1188395","canonicalSmiles":"NCc1cnc(S)n1[C@H]1CCc2c(F)cc(F)cc2C1","inchiKey":"YZZVIKDAOTXDEB-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEPICASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nepicastat","SYN-117","SYN117"],"crossReferences":{"drugbank":["DB12979"]},"childChemblIds":["CHEMBL536282"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1197","canonicalSmiles":"CC(CNC1CCCCC1)OC(=O)c1ccccc1","inchiKey":"DKLKMKYDWHYZTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXYLCAINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclaine","Hexylcaine","Osmocaine"],"crossReferences":{"Wikipedia":["Hexylcaine"],"drugbank":["DB00473"],"chEBI":["34791"]},"childChemblIds":["CHEMBL1200715"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL119888","canonicalSmiles":"O=C(O)c1ccccc1S","inchiKey":"NBOMNTLFRHMDEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOSALICYLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercapto-Benzoic Acid"],"crossReferences":{"PubChem":["144207109","170465571","855771"],"Wikipedia":["Thiosalicylic_acid"],"drugbank":["DB14026"],"chEBI":["59124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200375","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+]","inchiKey":"SHWNNYZBHZIQQV-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":true,"name":"EDETATE CALCIUM DISODIUM","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium Disodium Edetate","Calcium Disodium Edta","Calcium Disodium Versenate","Calcium Edetate Sodium","Calcium Edta","Edta Calcium Disodium","Edthamil","Sodium Calcium Edetate","Sodium Calciumedetate","Versene Ca"],"synonyms":["E385"],"crossReferences":{"DailyMed":["edetate%20calcium%20disodium"],"PubChem":["144205262"],"drugbank":["DB14598"]},"childChemblIds":["CHEMBL3989522"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for heavy metal poisoning and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200530","canonicalSmiles":"CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@@H]21.[Na+]","inchiKey":"GNWUOVJNSFPWDD-XMZRARIVSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"CEFOXITIN SODIUM","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL996","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefoxitin","Mefoxin"],"synonyms":["Cefoxitin sodium","Cefoxitin sodium salt"],"crossReferences":{"DailyMed":["cefoxitin%20sodium"],"PubChem":["144207034","56422171","8139890"],"chEBI":["3501"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for pneumonia and infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200614","canonicalSmiles":"O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I","inchiKey":"AMDBBAQNWSUWGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOVERSOL","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Optiray","Optiray 160","Optiray 240","Optiray 300","Optiray 320","Optiray 350"],"synonyms":["Ioversol","MP 328","MP-328"],"crossReferences":{"DailyMed":["ioversol"],"PubChem":["170464725"],"Wikipedia":["Ioversol"],"drugbank":["DB09134"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200641","canonicalSmiles":"COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1","inchiKey":"XXZSQOVSEBAPGS-DONVQRBFSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CISATRACURIUM BESYLATE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201248","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cisatracurium besylate","Cisatracurium besylate preservative free","Nimbex","Nimbex preservative free"],"synonyms":["51 W89","51-W-89","51-W89","51W-89","51W89","Cisatracurium (as besilate)","Cisatracurium besilate","Cisatracurium besylate"],"crossReferences":{"DailyMed":["cisatracurium%20besylate"],"PubChem":["11113043"],"chEBI":["3721"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_1000992","EFO_0000694","EFO_1001905","EFO_0005323","EFO_1000637"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1200661","canonicalSmiles":"CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)OC(C)C","inchiKey":"XXUPXHKCPIKWLR-JHUOEJJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNOPROSTONE ISOPROPYL","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rescula"],"synonyms":["Isopropyl unoprostone","UF-021","Unoprostone Isopropyl","Unoprostone isopropyl","Unoprostone isopropyl ester"],"crossReferences":{"PubChem":["144207178"],"chEBI":["31731"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for glaucoma and has 2 investigational indications."}
{"id":"CHEMBL1201334","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"VXKHXGOKWPXYNA-PGBVPBMZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRIPTORELIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decapeptyl","Decapeptyl sr","Gonapeptyl depot"],"synonyms":["AY-25650","Arvekap","CL 118,532","CL-118532","Triptodur","Triptorelin","Tryptorelin","WY-42462"],"crossReferences":{"DailyMed":["triptorelin%20pamoate"],"PubChem":["50112597"],"Wikipedia":["Triptorelin"],"drugbank":["DB06825"],"chEBI":["63633"]},"childChemblIds":["CHEMBL1200554"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_64739","EFO_0000545","EFO_1001757","EFO_0001065","EFO_0008560","EFO_0000180","MONDO_0007254","MONDO_0004669","EFO_0009867","EFO_0000305","MONDO_0008315","EFO_0001663","HP_0004322","EFO_0009029","EFO_0000512","MONDO_0000088","EFO_0000673","EFO_0000574","EFO_0000196"],"count":20},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 5 approved and 15 investigational indications."}
{"id":"CHEMBL1201414","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"TINZAPARIN SODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Innohep","Logiparin"],"synonyms":["LNH-1","LNH1","Tinzaparin","Tinzaparin na","Tinzaparin sodium","Tinzaparin sodium, porcine"],"crossReferences":{"Wikipedia":["Tinzaparin_sodium"]},"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0000365","HP_0001919","MONDO_0008170","EFO_0004286","EFO_0000495","EFO_0003060","EFO_0000311","EFO_0003106","HP_0001907","MONDO_0100096","MONDO_0000831","EFO_0003827","EFO_0003884","EFO_0003907","MONDO_0002367","EFO_0001378","HP_0004419","EFO_0000400","HP_0004936"],"count":20},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for deep vein thrombosis and recurrent thrombophlebitis and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201564","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON GAMMA-1B","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actimmune","Immukin"],"synonyms":["Ifn-.gamma.","Ifn-.gamma.1b","Imifn","Immune ifn","Interferon .gamma.-1b","Interferon gama-1b","Interferon gamma","Interferon gamma-1b","Interferon gamma-1b, recombinant","Interferon gamma-1b,recomb.","Interferon gamma-2a","Interferon-.gamma.","Interferon-.gamma. (human)"],"crossReferences":{"DailyMed":["interferon%20gamma-1b"],"Wikipedia":["Interferon-gamma"]},"linkedTargets":{"rows":["ENSG00000159128","ENSG00000027697"],"count":2},"linkedDiseases":{"rows":["EFO_0000637","EFO_0007183","MONDO_0015686","EFO_0000756","EFO_0000768","MONDO_0007254","Orphanet_586","EFO_0005952","MONDO_0002087","EFO_1001951","EFO_0007147","EFO_0000565","MONDO_0002158","EFO_0000588","EFO_0000389","EFO_0000676","EFO_0002918","EFO_0009429","Orphanet_379","EFO_0009869","EFO_0000616","EFO_1000811","EFO_1001359","MONDO_0008170","EFO_0004197","EFO_1001282","Orphanet_95","MONDO_0008315","EFO_0009448","EFO_0000621","Orphanet_398934","EFO_0007228","EFO_0007460","EFO_0004220","EFO_0001422","Orphanet_53","EFO_1001231","EFO_0000174","EFO_0000764","EFO_0000574","MONDO_0004580","EFO_1001051","Orphanet_2781","EFO_0001378","EFO_0007386"],"count":45},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 38 investigational indications."}
{"id":"CHEMBL1201606","drugType":"Antibody","blackBoxWarning":false,"name":"IBRITUMOMAB TIUXETAN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zevalin","Zevalin Kit-Indium-111"],"synonyms":["IDEC-129","IDEC-IN2B8","IDEC-Y2B8","IDEC-Y2B8 IDEC-129","Ibritumomab tiuxetan"],"crossReferences":{"DailyMed":["ibritumomab%20tiuxetan"],"DrugCentral":["4984"],"Wikipedia":["Ibritumomab_tiuxetan"]},"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0013730","MONDO_0000873","MONDO_0019465","EFO_0000403","EFO_1001469","EFO_0005952","EFO_0000565","EFO_0000309","EFO_1001365","EFO_0000096","EFO_0000095","MONDO_0019088","EFO_0000191","EFO_0000574","MONDO_0018906","EFO_0000183","EFO_0001378","EFO_1000550"],"count":19},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 16 investigational indications."}
{"id":"CHEMBL1201830","drugType":"Protein","blackBoxWarning":false,"name":"RILONACEPT","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arcalyst"],"synonyms":["IL-1 TRAP","IL-1-TRAP","INTERLEUKIN-1 TRAP","KPL-914","Kpl-914","Rilonacept"],"crossReferences":{"DailyMed":["rilonacept"],"DrugCentral":["5105"],"Wikipedia":["Rilonacept"]},"linkedTargets":{"rows":["ENSG00000125538"],"count":1},"linkedDiseases":{"rows":["Orphanet_575","EFO_0004274","EFO_1001345","EFO_0000540","EFO_0002609","Orphanet_210115","EFO_0000404","EFO_1001999","MONDO_0005147","EFO_0003884","Orphanet_47045","Orphanet_208650","EFO_0007427","EFO_0004238","Orphanet_342","EFO_1001881"],"count":16},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL1224151","canonicalSmiles":"COc1cc(/C=C2\\CCCN([C@@H](C)c3ccc(F)cc3)C2=O)ccc1-n1cnc(C)c1","inchiKey":"PUOAETJYKQITMO-LANLRWRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1224151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05171"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234696","canonicalSmiles":"O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2F)c([N+](=O)[O-])c1","inchiKey":"UFSBFVZQJZMIOU-LZQZFOIKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234696","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50106143","50106144","90340709"],"drugbank":["DB02658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235106","canonicalSmiles":"CCOCCOCCOCC","inchiKey":"RRQYJINTUHWNHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235106","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212367"],"drugbank":["DB08357"],"chEBI":["44664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235702","canonicalSmiles":"CC[C@H](CO)Nc1nc(N(C)Cc2ccccc2)c2ncn(C(C)C)c2n1","inchiKey":"YPYWONAECUVKHY-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04776"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236230","canonicalSmiles":"CO[C@@H](C(=O)N[C@H]1CC[C@@H](O)CNC1=O)[C@H](O)[C@@H](O)[C@H](O)/C=C/C(C)(C)C","inchiKey":"FVBBTOIQETYGOA-SDNORSGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236230","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237054","canonicalSmiles":"CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@@H]2C[C@@H](O)[C@@H](O[C@@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@H](O)[C@@H](C)O1","inchiKey":"XDKMHMINQXATOR-RCFLUEAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLICAMYCIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mithracin"],"synonyms":["A-2371","ANTIBIOTIC LA-7017","Aureolic acid","LA-7017","Mithramycin","Mithramycin a","NSC-24559","PA-144","Plicamycin"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for neoplasm and has 1 investigational indication."}
{"id":"CHEMBL1255654","canonicalSmiles":"CCCCNc1ccc(C(=O)OCCN(C)C)cc1.Cl","inchiKey":"PPWHTZKZQNXVAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACAINE HYDROCHLORIDE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL698","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anethaine","Locan","Pontocaine hydrochloride","Tetracaine hydrochloride"],"synonyms":["Amethocaine hydrochloride","Butethanol","Curtacain","Dicainum","Menonasal","NSC-757337","Pantocaine","Tetocaine","Tetraca","Tetracaine hcl","Tetracaine hydrochloride","Tetracaini hydrochloridum"],"crossReferences":{"DailyMed":["tetracaine%20hydrochloride"],"PubChem":["11533049","144203841","170465190","26747689","26747690","50107143","50107144","50107145","85273695"]},"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0009540"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2016."}
{"id":"CHEMBL130","canonicalSmiles":"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl","inchiKey":"WIIZWVCIJKGZOK-RKDXNWHRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORAMPHENICOL","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hematological toxicity"],"year":2012},"tradeNames":["Amphicol","Brochlor","Brolene antibiotic","Chloramex","Chloramphenicol","Chlorbiotic","Chlorofair","Chloromycetin","Chloroptic","Chloroptic s.o.p.","Econochlor","Golden eye antibiotic","Kemicetine","Kernispray","Klorafect","Mychel","Ophthochlor","Optomycin","Sno phenicol","Tevcocin","Tubilux infected eyes"],"synonyms":["9-hydroxy-9-phenylxanthene","9-phenyl-9h-xanthen-9-ol","Chloramphenicol","Mychel-S","NSC-16331","NSC-3069","Xanthen-9-ol, 9-phenyl-"],"crossReferences":{"PubChem":["144204859","144214022","17389985","26752873","47193729","49734345","50105494","69616"],"TG-GATEs":["64"],"Wikipedia":["Chloramphenicol"],"drugbank":["DB00446"],"chEBI":["17698"]},"childChemblIds":["CHEMBL2205638"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 3 approved and 1 investigational indication. It was withdrawn in United States  in 2012 due to Hematological toxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL134713","canonicalSmiles":"COc1ccc(/C=C2\\CCCN=C2c2cccnc2)c(OC)c1","inchiKey":"RPYWXZCFYPVCNQ-RVDMUPIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GTS-21","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(2,4-Dimethoxybenzylidene)Anabaseine","Dimethoxybenzylidene anabaseine","Dmxb-a","Gts-21"],"crossReferences":{"drugbank":["DB05708"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1388","canonicalSmiles":"Oc1ccc(OCc2ccccc2)cc1","inchiKey":"VYQNWZOUAUKGHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOBENZONE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benoquin"],"synonyms":["Monobenzone","Monobenzyl ether of hydroquinone","NSC-2132","P-(benzyloxy)phenol","P-benzyloxyphenol"],"crossReferences":{"PubChem":["11112252","144203947","144208345","170464724","174006811"],"Wikipedia":["Monobenzone"],"drugbank":["DB00600"],"chEBI":["34380"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1952."}
{"id":"CHEMBL14882","canonicalSmiles":"Nc1ccc2c(=O)[nH][nH]c(=O)c2c1","inchiKey":"HUDPLKWXRLNSPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL14882","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89850458"],"drugbank":["DB02041"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1512580","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1","inchiKey":"WJJYZXPHLSLMGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XALIPRODEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR 57746","SR-57746","Xaliproden"],"crossReferences":{"PubChem":["50112828","50112829"],"drugbank":["DB06393"],"chEBI":["48520"]},"childChemblIds":["CHEMBL3183486"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","MONDO_0004975","EFO_0004142"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1562610","canonicalSmiles":"Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]","inchiKey":"QHJLLDJTVQAFAN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"MECLOFENAMATE SODIUM","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL509","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Meclodium","Meclofenamate sodium","Meclomen"],"synonyms":["CL-583.NA SALT","Meclofenamate sodium","Meclofenamate sodium anhydrous","Meclofenamate sodium hydrate","Meclofenamic acid sodium","NSC-757088","Sodium meclofenamate","Sodium meclofenamate monohydrate"],"crossReferences":{"DailyMed":["meclofenamate%20sodium"],"PubChem":["11112978","144204315","170464886","85273783"],"chEBI":["76232"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":3},"linkedDiseases":{"rows":["EFO_0000685","HP_0001945","HP_0100607","MONDO_0005178","EFO_0002609"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 5 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1570266","canonicalSmiles":"CCCC(=O)OC(C(Cl)(Cl)Cl)P(=O)(OC)OC","inchiKey":"BKAQXYNWONVOAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butonate","ENT-20852","NSC-17872","Trichlorfon butanoic acid ester"],"crossReferences":{"PubChem":["144205461","29216254"],"drugbank":["DB11379"],"chEBI":["82106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15722","canonicalSmiles":"Cc1cccnc1","inchiKey":"ITQTTZVARXURQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLPYRIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Picoline"],"crossReferences":{"PubChem":["144209164","144213318","17389601","49718209"],"Wikipedia":["3-Methylpyridine"],"drugbank":["DB01996"],"chEBI":["39922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1614658","canonicalSmiles":"NC(=O)OC[C@@H]1[C@H](NC(=O)/C(=N\\OCC(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O","inchiKey":"UIMOJFJSJSIGLV-JNHMLNOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARUMONAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carumonam"],"crossReferences":{"drugbank":["DB13553"],"chEBI":["55486"]},"childChemblIds":["CHEMBL2104060"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1617398","canonicalSmiles":"Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F","inchiKey":"NOOCSNJCXJYGPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNIXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flunixin","SCH 14714","SCH-14714"],"crossReferences":{"drugbank":["DB11518"],"chEBI":["76138"]},"childChemblIds":["CHEMBL3561935","CHEMBL2358115","CHEMBL1733447","CHEMBL1314975"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742461","canonicalSmiles":"O=C(C[S+]([O-])Cc1ccco1)NC/C=C\\COc1cc(CN2CCCCC2)ccn1","inchiKey":"KMZQAVXSMUKBPD-DJWKRKHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAFUTIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lafutidine"],"crossReferences":{"PubChem":["144205732","170465978"],"drugbank":["DB12770"]},"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398","EFO_0009454","EFO_0000337"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1760","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(O)cc(O)c1","inchiKey":"XWTYSIMOBUGWOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TERBUTALINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Asthmasian","Brethaire","Brethine","Bricanyl","Terbutalin","Terbutaline"],"crossReferences":{"DailyMed":["terbutaline%20sulfate"],"PubChem":["90341646"],"Wikipedia":["Terbutaline"],"drugbank":["DB00871"],"chEBI":["9449"]},"childChemblIds":["CHEMBL1315867","CHEMBL1160544"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0006536","EFO_0008590","EFO_0003144","MONDO_0005147","EFO_0009661","MONDO_0004979","EFO_0000341","HP_0025428","EFO_0003843"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 4 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1765293","canonicalSmiles":"C=C(C)CNc1ccc(C(C)C(=O)O)cc1","inchiKey":"FPHLBGOJWPEVME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMINOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alminoprofen","Minalfen"],"crossReferences":{"Wikipedia":["Alminoprofen"],"drugbank":["DB13314"],"chEBI":["31190"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1788403","canonicalSmiles":"C=CCC1=C(C)C(OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O","inchiKey":"ZCVAOQKBXKSDMS-AQYZNVCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIOALLETHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allethrin","Bioallethrin","Depallethrin","Esbiothrin","NSC-11782","Trans-allethrin"],"crossReferences":{"chEBI":["39118"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1908373","canonicalSmiles":"CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1","inchiKey":"IEXUMDBQLIVNHZ-YOUGDJEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONAPRISTONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Onapristone","ZK-299","ZK-98299","ZK299","Zk-98299","Zk98299"],"crossReferences":{"drugbank":["DB12637"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0000196","EFO_1000233"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL193233","canonicalSmiles":"COc1ccc(-c2ccccc2)cc1N1CC(=O)NS1(=O)=O","inchiKey":"IGXKSKWHHHYBFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL193233","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08591"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL196526","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(N)=O","inchiKey":"KPMMESISHWWXNM-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL196526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07651"],"chEBI":["47379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2012520","canonicalSmiles":"CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12","inchiKey":"RBSGUQYXRDKPAE-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY377604","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-377604","Ly-377604","Ly377604"],"crossReferences":{"drugbank":["DB12858"]},"childChemblIds":["CHEMBL2012522","CHEMBL2012521"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL206109","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cc(OCC3CCCCC3)nc3ncnn23)cc1","inchiKey":"NMAZGYDYIYLSLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL206109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2063705","canonicalSmiles":"CNC(=O)C[C@@H]1NC(=O)c2csc(n2)-c2ccc(-c3nc(N(CCCCC(=O)O)C(=O)O[C@H]4CC[C@H](C(=O)O)CC4)cs3)nc2-c2csc(n2)-c2csc(n2)[C@H]([C@@H](O)c2ccccc2)NC(=O)CNC(=O)c2nc(sc2COC)[C@H](C(C)C)NC(=O)c2nc1sc2C","inchiKey":"GNLYKLDXQZHYTR-LMOGNUDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LFF-571","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.333.591A","LFF571","Lff-571"],"crossReferences":{"drugbank":["DB13013"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104523","canonicalSmiles":"CCOc1cc(N)c([N+](=O)[O-])cc1C(=O)NC1CCN(CC2CC=CCC2)CC1","inchiKey":"ZDLBNXXKDMLZMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINITAPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinitapride","Paxapride"],"crossReferences":{"drugbank":["DB08810"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105345","canonicalSmiles":"CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1","inchiKey":"KEJXLQUPYHWCNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANIDID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Immune system toxicity"],"year":1983},"tradeNames":["Epontol"],"synonyms":["BAYER 1420","BAYER-1420","FBA 1420","FBA-1420","Propanidid","TH-2180","WH 5668","WH-5668"],"crossReferences":{"PubChem":["144206858"],"drugbank":["DB13234"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1983 due to Immune system toxicity."}
{"id":"CHEMBL2105762","canonicalSmiles":"CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2","inchiKey":"MKMPWKUAHLTIBJ-ISTRZQFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMARIGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-3102","Omarigliptin"],"crossReferences":{"drugbank":["DB11992"]},"childChemblIds":["CHEMBL3234203"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105763","canonicalSmiles":"Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21","inchiKey":"PAWIYAYFNXQGAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUISINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ 26481585","JNJ-26481585","Quisinostat"],"crossReferences":{"drugbank":["DB12985"]},"childChemblIds":["CHEMBL3039527"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107486","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(SC3CN(C4=NCCS4)C3)[C@H](C)[C@H]12","inchiKey":"SNUDIPVBUUXCDG-QHSBEEBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEBIPENEM PIVOXIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orapenem"],"synonyms":["L-084","LJC 11,084","LJC 11084","LJC-11084","ME-1211","ME1211","TBPM-PI","Tebipenem pivoxil"],"childChemblIds":["CHEMBL4297677"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107869","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN DEGLUDEC","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ins tresiba","Tresiba"],"synonyms":["Insulin degludec","NN-1250","NN1250"],"crossReferences":{"DailyMed":["insulin%20degludec"],"DrugCentral":["4960"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0005148","EFO_0000400"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL2107911","drugType":"Protein","blackBoxWarning":false,"name":"ONERCEPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Onercept","R-HTBP-1"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0003778"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107917","drugType":"Antibody","blackBoxWarning":false,"name":"OREGOVOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ovarex"],"synonyms":["Oregovamab","Oregovomab","mAb-B43.13"],"linkedTargets":{"rows":["ENSG00000181143"],"count":1},"linkedDiseases":{"rows":["EFO_1000044","MONDO_0002158","EFO_0003893","EFO_0001075","MONDO_0008170","MONDO_0002087"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108286","drugType":"Protein","blackBoxWarning":false,"name":"TUROCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NN-7008","NN7008","Novoeight","Turoctocog alfa"],"crossReferences":{"DrugCentral":["5019"]},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108342","drugType":"Antibody","blackBoxWarning":false,"name":"GEMTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gemtuzumab","Hp 67.6"],"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108576","drugType":"Antibody","blackBoxWarning":false,"name":"BAPINEUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3D-6","AAB-001","AAB-001, Humanized 3D-6 Monoclonal Antibody","Bapineuzumab","HUMANIZED 3D-6 MONOCLONAL ANTIBODY"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108603","drugType":"Protein","blackBoxWarning":false,"name":"HEMOGLOBIN GLUTAMER-250 (BOVINE)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hemopure"],"synonyms":["HBOC-201","Hemoglobin glutamer-250 (bovine)"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108683","drugType":"Unknown","blackBoxWarning":false,"name":"ENTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cblb502"],"synonyms":["CBLB-502","CBLB502","Entolimod"],"linkedTargets":{"rows":["ENSG00000187554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003890","EFO_1001951"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108793","drugType":"Enzyme","blackBoxWarning":false,"name":"TILACTASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-galactosidase (aspergillus)","G9S0VV191I","Galactosidase","Tilactase"],"description":"Enzyme drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109037","drugType":"Protein","blackBoxWarning":false,"name":"ILODECAKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tenovil"],"synonyms":["Il-10 (nonglycosylated)","Ilodecakin","Interleukin-10 ilodecakin","Prevascar","SCH 52000","SCH-52000","Sh-polypeptide-6"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109545","drugType":"Antibody","blackBoxWarning":false,"name":"TB-403","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7334","RO-5323441","TB-403","TB403","THR-317","Tb-403","Thr 317"],"linkedTargets":{"rows":["ENSG00000119630"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109583","drugType":"Antibody","blackBoxWarning":false,"name":"F16IL2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F16IL2","F16il2"],"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["EFO_1001471","MONDO_0007254","EFO_0000222"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110703","canonicalSmiles":"CCNC1(c2cccs2)CCCCC1=O","inchiKey":"QAXBVGVYDCAVLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiletamine"],"crossReferences":{"drugbank":["DB11549"]},"childChemblIds":["CHEMBL2105342"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110727","canonicalSmiles":"CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1","inchiKey":"PNDKCRDVVKJPKG-WHERJAGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENICRIVIROC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenicriviroc","TAK-652","TBR-652"],"crossReferences":{"drugbank":["DB11758"]},"childChemblIds":["CHEMBL2105686"],"linkedTargets":{"rows":["ENSG00000160791","ENSG00000121807"],"count":2},"linkedDiseases":{"rows":["EFO_0004268","MONDO_0100096","EFO_0000544","EFO_0003095","EFO_0000764","EFO_0000180","EFO_0001421","EFO_1001249"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2141712","canonicalSmiles":"COc1ccc(COc2cc3oc(=O)c4cc(C(C)O)ccc4c3cc2OC)cc1","inchiKey":"YEAHTLOYHVWAKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOMID-529","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-529","P529","PALOMID-529","Palomid 529","Palomid-529","SG 00529","SG-00529"],"crossReferences":{"PubChem":["137275969"],"drugbank":["DB12812"]},"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2216870","canonicalSmiles":"CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1","inchiKey":"IFSDAJWBUCMOAH-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IDELALISIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zydelig"],"synonyms":["CAL-101","GS-1101","GS-11CAL-101","Idelalisib"],"crossReferences":{"DailyMed":["idelalisib"],"drugbank":["DB09054"],"chEBI":["82701"]},"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000616","EFO_0005854","MONDO_0000432","MONDO_0044903","EFO_0000220","EFO_0001642","EFO_0000403","EFO_0000222","EFO_1001875","EFO_1001469","EFO_0005952","EFO_0000311","EFO_0000096","EFO_0000095","EFO_0002517","EFO_0000574","MONDO_0018906","EFO_0001378","EFO_0000183"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2360464","canonicalSmiles":"Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+]","inchiKey":"NYDXNILOWQXUOF-GXKRWWSZSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMETREXED DISODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL225072","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alimta"],"synonyms":["LY-231514 DISODIUM SALT","LY231514 DISODIUM SALT","Pemetrexed disodium","Pemetrexed disodium heptahydrate","Pemetrexed sodium hydrate","Pemetrexed sodium salt"],"crossReferences":{"DailyMed":["pemetrexed%20disodium"],"PubChem":["144206040"],"chEBI":["63722"]},"linkedTargets":{"rows":["ENSG00000176890","ENSG00000228716","ENSG00000159131"],"count":3},"linkedDiseases":{"rows":["EFO_0000365","MONDO_0004192","EFO_0000571","MONDO_0021117","MONDO_0007254","EFO_0000708","MONDO_0002087","EFO_0000308","MONDO_0020654","MONDO_0001187","EFO_1001951","MONDO_0001056","MONDO_0002158","EFO_0000588","EFO_0003860","MONDO_0002974","EFO_0000770","MONDO_0008903","EFO_0008528","EFO_0000616","EFO_0002618","EFO_0006859","Orphanet_59305","MONDO_0008170","MONDO_0000521","EFO_0003060","EFO_1000124","MONDO_0008315","EFO_0000311","EFO_0009708","EFO_1000576","EFO_0003863","EFO_1000581","MONDO_0011962","EFO_0000233","EFO_0000574","MONDO_0024880","EFO_0000691","EFO_0003050"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for non-small cell lung carcinoma and has 34 investigational indications."}
{"id":"CHEMBL246600","canonicalSmiles":"COc1ccc(C[C@@H](O)c2cc(OC)c(OC)c(OC)c2)cc1O","inchiKey":"LGZKGOGODCLQHG-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COMBRETASTATIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-combretastatin","(r)-(-)-combretastatin","Combretastatin","Combretastatin, (-)-","NSC-348103"],"crossReferences":{"drugbank":["DB12596"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL262075","canonicalSmiles":"CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1","inchiKey":"CBIAWPMZSFFRGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIPLON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL-285489","Calenthys","Indiplon","NBI-34060"],"crossReferences":{"PubChem":["174006212"],"Wikipedia":["Indiplon"],"drugbank":["DB12590"]},"linkedTargets":{"rows":["ENSG00000022355"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL28198","canonicalSmiles":"CCC(=O)N(c1ccccc1)[C@@]1(C(=O)OC)CCN(CCc2ccccc2)C[C@H]1C","inchiKey":"IMYHGORQCPYVBZ-NLFFAJNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFENTANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Lofentanil"],"drugbank":["DB09174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289422","canonicalSmiles":"O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@H]1CC[C@@H]3O1","inchiKey":"OTPNDVKVEAIXTI-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL289422","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292268","canonicalSmiles":"Cn1cnc(N)c2ncnc1-2","inchiKey":"FSASIHFSFGAIJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLADENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04104"],"chEBI":["38635"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL299613","canonicalSmiles":"COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12","inchiKey":"CQOQDQWUFQDJMK-SSTWWWIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-METHOXYESTRADIOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-methoxyestradiol","2-methoxyoestradiol","NSC-659853"],"crossReferences":{"PubChem":["11532969","124891665","50106559","50106560","56423644","90340800"],"Wikipedia":["2-Methoxyestradiol"],"drugbank":["DB02342"],"chEBI":["28955"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL303296","canonicalSmiles":"CC(C)C[C@H](N)C(=O)NO","inchiKey":"UJJHPFLWSVFLBE-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303296","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03308"]},"childChemblIds":["CHEMBL4742824"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039503","canonicalSmiles":"CC(C)(C)C#Cc1cc(N(C(=O)[C@H]2CC[C@H](C)CC2)[C@H]2CC[C@H](O)CC2)c(C(=O)O)s1","inchiKey":"WPMJNLCLKAKMLA-VVPTUSLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMIBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lomibuvir","VX-222","Vch-222"],"crossReferences":{"drugbank":["DB11954"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL329137","canonicalSmiles":"O=P(O)(O)O[C@H]1[C@@H](O)[C@@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@@H]1OP(=O)(O)O","inchiKey":"MMWCIQZXVOZEGG-MLQGYMEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329137","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01729"],"chEBI":["18228"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544927","drugType":"Small molecule","blackBoxWarning":false,"name":"L-21649","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-21649"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544975","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NCC1CCN(CC[C@H](OC(N)=O)c2ccc(F)cc2)CC1","inchiKey":"KGMMSPVVHZGPHL-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELENOPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Relenopride","YKP-10811","YKP10811"],"crossReferences":{"drugbank":["DB12798"]},"childChemblIds":["CHEMBL3544976"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545027","canonicalSmiles":"COC(=O)Nc1nc2cc(C3(O)c4ccccc4C(=O)N3c3cc(Cl)ccc3C)ccc2[nH]1","inchiKey":"MMNNTJYFHUDSKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-281","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-908662","Bms-908662 free base","EXEL-2819","Xl 281","Xl-281"],"crossReferences":{"drugbank":["DB12854"]},"linkedTargets":{"rows":["ENSG00000157764","ENSG00000132155"],"count":2},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000641","EFO_0003060","EFO_1001951"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545226","drugType":"Small molecule","blackBoxWarning":false,"name":"ACUMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acumapimod","Bct-197"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545274","canonicalSmiles":"CC(C)(C)n1nnc2c3c(ccc21)C1=CC(=O)CC[C@@]1(CCOc1ccccc1)C3","inchiKey":"LYLIIGQPIKTONH-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-6913","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-6913"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545332","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-2563","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cep-2563","KT-8391"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545360","canonicalSmiles":"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1","inchiKey":"MGGBYMDAPCCKCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASP-3026","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP3026","Asp 3026","Asp-3026"],"crossReferences":{"drugbank":["DB12729"]},"linkedTargets":{"rows":["ENSG00000171094"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000096","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545373","drugType":"Antibody","blackBoxWarning":false,"name":"ENOBLITUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enoblituzumab","Inc.","MGA-271","MGA271","MacroGenics"],"linkedTargets":{"rows":["ENSG00000103855"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0008315","EFO_0000181"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL357488","canonicalSmiles":"COC(=O)c1cc(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(Cc3ccc(-c4ccccc4)cc3)C2=O)ccc1C(F)(C(=O)O)C(=O)O","inchiKey":"RLLAUERCSKPFGD-VMPREFPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL357488","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02432"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL364804","canonicalSmiles":"CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1","inchiKey":"NXMZBNYLCVTRGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW-406381","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gw 406381","Gw-406381","Gw406381"],"crossReferences":{"drugbank":["DB12009"]},"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0010072","EFO_0004616","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3655762","canonicalSmiles":"CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O","inchiKey":"DLPIYBKBHMZCJI-WBVHZDCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3655762","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15425"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707289","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O","inchiKey":"TZGKQIBPZOZAKF-PJLVGBPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROERGOCRYPTINE MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1743263","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydroergocryptine mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707302","canonicalSmiles":"CC(=O)CCC(=O)[O-].CC(=O)CCC(=O)[O-].[Mg+2]","inchiKey":"RECCGACJWKEPOU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM LEVULINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1235931","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium levulinate"],"crossReferences":{"DrugCentral":["4593"],"drugbank":["DB14514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707392","canonicalSmiles":"O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1","inchiKey":"YNUAEEJQYHYLMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELECLAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eleclazine","GS-6615"],"crossReferences":{"drugbank":["DB12394"]},"childChemblIds":["CHEMBL3972607"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL374699","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)n1","inchiKey":"NCMVOABPESMRCP-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-Deoxycytidinemonophosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxycytidinemonophosphate"],"crossReferences":{"Wikipedia":["Deoxycytidine_monophosphate"],"drugbank":["DB03798"],"chEBI":["15918"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL375270","canonicalSmiles":"O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl","inchiKey":"DNTSIBUQMRRYIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW9662","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW9662"],"crossReferences":{"PubChem":["11114114","124880752","124880754","124880755","124880756","144212310","26732595","26752210","26752211","50104878","85231138","90341221"],"drugbank":["DB07863"],"chEBI":["79993"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL375951","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"HSCJRCZFDFQWRP-JZMIEXBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE DIPHOSPHATE GLUCOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-Diphosphoglucose","UDPG","Udp-Glucose","Uridine Diphosphate Glucose","Uridine-5'-Diphosphoglucose"],"crossReferences":{"Wikipedia":["Uridine_diphosphate_glucose"],"drugbank":["DB01861"],"chEBI":["46229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833337","drugType":"Small molecule","blackBoxWarning":false,"name":"DICOBALT EDETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kelocyanor"],"synonyms":["Dicobalt edetate","Edta cobalt salt"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL386015","canonicalSmiles":"O=C(N[C@@H]1Cc2ccccc2[C@H]1O)c1cc2cc(Cl)sc2[nH]1","inchiKey":"LRHOLHTVXXSIMG-BXUZGUMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL386015","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989798","canonicalSmiles":"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O.O.O=C(O)/C=C/C(=O)O","inchiKey":"RATSWNOMCHFQGJ-XODSYJLDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FORMOTEROL FUMARATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1256786","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atimos modulite","Foradil","Foradil certihaler","Oxis 12","Oxis 6","Performist","Perforomist"],"synonyms":["Atock","BD 40A","BD-40A","CGP 25827A","CGP-25827A","Eformoterol","Fomoterol fumarate","Foraseq","Formoterol fumarate","Formoterol fumarate (superceded)","Formoterol fumarate anhydrous","Formoterol fumarate dihydrate","Formoterol fumarate hydrate","Formoterol hemifumarate","NSC-299587","Oxeze","YM-08316"],"crossReferences":{"DailyMed":["formoterol%20fumarate","formoterol%20fumarate%20dihydrate"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0007183","EFO_0000464","EFO_0009661","MONDO_0005271","EFO_0003768","EFO_1000637","HP_0002110","MONDO_0100096","EFO_0000684","MONDO_0008903","EFO_0006505","MONDO_0004975","MONDO_0004979","EFO_0000341","HP_0025428"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989805","canonicalSmiles":"CN1CCN(c2ccccc2/C=C2\\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1.Cl","inchiKey":"NMTRXBJYASHMND-UXTSPRGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELZASONAN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3185463","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-448,187-01","Cp-448187-01","Elzasonan hcl","Elzasonan hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989843","canonicalSmiles":"N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1","inchiKey":"IGLYMJRIWWIQQE-QUOODJBBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRANYLCYPROMINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-80664","Tranylcypromine"],"crossReferences":{"DailyMed":["tranylcypromine%20sulfate"]},"childChemblIds":["CHEMBL3989698"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0005090","EFO_0000289","MONDO_0002050","MONDO_0002009","HP_0000726","EFO_0005252","EFO_0000222","EFO_0003761","EFO_1002014","EFO_0005230"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989870","canonicalSmiles":"CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1","inchiKey":"JZCWLJDSIRUGIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERZOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berzosertib","M-6620","M6620","VE-822","VX-970","VX970","Vx-970"],"crossReferences":{"drugbank":["DB11794"]},"linkedTargets":{"rows":["ENSG00000175054"],"count":1},"linkedDiseases":{"rows":["EFO_0001416","EFO_0000616","EFO_0002618","EFO_0003893","EFO_0001075","EFO_0000365","EFO_1001958","MONDO_0015686","MONDO_0008170","EFO_1001973","EFO_0000305","EFO_0003060","MONDO_0044704","EFO_1001480","EFO_0000564","EFO_0006352","EFO_1000251","EFO_0000196","EFO_0000702","EFO_0000199","EFO_0006544","MONDO_0024880","EFO_1001960"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL3989885","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.O=C(O)C(O)C(O)C(=O)O","inchiKey":"AJZJIYUOOJLBAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMEPRAZINE TARTRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL829","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Temaril","Trimeprazine tartrate","Vallergan","Vallergan fte"],"synonyms":["Alimemazine hemitartrate","Alimemazine tartrate","Methylpromazine tartrate","NSC-17475","NSC-757358","Panectyl","Repeltin","Theralene","Trimeprazine hemitartrate","Trimeprazine tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3989993","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"COBOMARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobomarsen","M-11667 FREE ACID","M11667","M11667 FREE ACID","MRG-106","MRG-106 FREE ACID"],"linkedTargets":{"rows":["ENSG00000283904"],"count":1},"linkedDiseases":{"rows":["EFO_1001051"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL407874","canonicalSmiles":"Nc1nc(OCc2ccccc2)c2nc[nH]c2n1","inchiKey":"KRWMERLEINMZFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-O-BENZYLGUANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-o-benzylguanine","NSC-637037","O(6)-benzylguanine","O6-benzylguanine"],"crossReferences":{"PubChem":["11110835","46500408","49674655","498466","50105918","50105919","85230936","90341638"],"drugbank":["DB11919"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL4089083","canonicalSmiles":"O/N=c1\\cc(-c2cc3sccc3cn2)oc2ccc(CCCN3CCOCC3)cc12","inchiKey":"ZTEDNASHAWNBKQ-NCELDCMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLIGLURAX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DT-1687","DT1687","Foliglurax","PXT-002331","PXT002331","Pxt002331"],"crossReferences":{"drugbank":["DB15292"]},"linkedTargets":{"rows":["ENSG00000124493"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL409803","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C","inchiKey":"JYPVVOOBQVVUQV-CGHBYZBKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANGIOTENSIN AMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Angiotensin amide","Angiotensinamide","Asn-arg-val-tyr-val-his-pro-phe","NSC-107678"],"crossReferences":{"Wikipedia":["Angiotensinamide"],"drugbank":["DB13517"]},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4110551","canonicalSmiles":"COC(=O)NCCCn1nc([C@@H](C)N(C(=O)[C@H]2CNCCO2)C2CC2)c2ccc(C)nc21","inchiKey":"GRTDDIZIUSADLD-CRAIPNDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPH-3127","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SPH-3127","SPH3127","Sph-3127","Sph3127"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL424278","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)NC(=O)CCl)CO2","inchiKey":"MSHZHSPISPJWHW-PVDLLORBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O-CHLOROACETYLCARBAMOYLFUMAGILLOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGM-1470","NSC-642492","O-chloroacetylcarbamoylfumagillol","TNP-470","Tnp-470"],"crossReferences":{"PubChem":["501161"],"drugbank":["DB08633"],"chEBI":["90748"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297272","drugType":"Small molecule","blackBoxWarning":false,"name":"COBALAMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobalamin"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297312","canonicalSmiles":"COC[C@@]1(C)CCCN2CCc3c(oc4ccccc34)[C@@H]21","inchiKey":"OCUKPFWNSAAHRP-QZTJIDSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORM-12741","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORM-10921","Orm-12741"],"crossReferences":{"drugbank":["DB12057"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297315","canonicalSmiles":"N=C(N)c1ccc2nc(-c3cc(CC(=O)N[C@@H](CC(=O)O)C(=O)O)cc(-c4cc(S(N)(=O)=O)ccc4O)c3O)[nH]c2c1","inchiKey":"WDJHHCAKBRKCLW-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PCI-27483","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pci-27483"],"crossReferences":{"drugbank":["DB13000"]},"linkedTargets":{"rows":["ENSG00000057593"],"count":1},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297375","canonicalSmiles":"Cc1cnc(C[S@@+]([O-])c2nc3ccccc3[n-]2)c(C)c1OCC1COC(C)(C)OC1.[Na+]","inchiKey":"HXDOUUHARCBYLF-VNUFCWELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELOPRAZOLE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4300945","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azeloprazole sodium","E-3710","E3710"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297418","canonicalSmiles":"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](COC(=O)CO)C3)c2n1","inchiKey":"ZBBZROWQLKCFQK-KOLCDFICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABACAVIR HYDROXYACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abacavir hydroxyacetate","Prurisol"],"crossReferences":{"drugbank":["DB12187"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297442","canonicalSmiles":"OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O","inchiKey":"YGIDGBAHDZEYMT-MQFIMZJJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TD-139","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GB-0139","GB0139","TD-139","TD139","Td 139","Td-139","Td139"],"crossReferences":{"drugbank":["DB12895"]},"linkedTargets":{"rows":["ENSG00000131981"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000768"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297447","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)O","inchiKey":"XIEWFECSPPTVQN-KMIMAYJXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRV-120027","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sar-val-tyr-ile-his-pro-d-ala-oh","TRV 027","TRV-027","TRV027","Trv-120027","Trv027","Trv120027"],"crossReferences":{"drugbank":["DB12199"]},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297499","canonicalSmiles":"CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@@H](C)[C@@H]1OC(=O)C(C)C","inchiKey":"XJBILYMRFVHPJB-XJQUKVTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TMC-649128","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TMC-649128","TMC649128","Tmc-649128","Tmc649128"],"crossReferences":{"drugbank":["DB15152"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297503","canonicalSmiles":"COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O","inchiKey":"RZVPBGBYGMDSBG-GGAORHGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALOXAVIR MARBOXIL","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xofluza"],"synonyms":["Baloxavir marboxil","S-033188"],"crossReferences":{"DailyMed":["baloxavir%20marboxil"],"drugbank":["DB13997"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for viral disease and influenza."}
{"id":"CHEMBL4297522","canonicalSmiles":"CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21","inchiKey":"HCDMJFOHIXMBOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMIGATINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pemazyre"],"synonyms":["Fgfr inhibitor incb054828","INCB054828","Incb-054828","Incb054828","Pemigatinib"],"crossReferences":{"DailyMed":["pemigatinib"],"drugbank":["DB15102"]},"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782"],"count":3},"linkedDiseases":{"rows":["EFO_1001951","EFO_0000616","EFO_0002618","EFO_0003863","EFO_0004251","MONDO_0011962","EFO_0008528","EFO_0000222","EFO_0003060","EFO_0005221","EFO_0000519","MONDO_0001187","EFO_0000311"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL4297547","drugType":"Unknown","blackBoxWarning":false,"name":"COCO DIETHANOLAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alkamide 101-cg","Amidex ce surfactant","Calamide c","Cocamide dea","Cocamide diethanolamine","Coco diethanolamide","Cocodiethanolamide","Coconut diethanolamide","N,n-bis(hydroxyethyl)cocamine"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297716","drugType":"Unknown","blackBoxWarning":false,"name":"CARBOGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbogen","Meduna's mixture"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297727","drugType":"Unknown","blackBoxWarning":false,"name":"CHOLINE MAGNESIUM TRISALICYLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Choline magnesium salicylate","Choline magnesium trisalicylate","NSC-751675","Trilisate"],"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4297799","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGTIBATINASE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["20nhs peg-cbs","OT-58","Ot-58","Pegtibatinase","TVT-058"],"description":"Enzyme drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298046","drugType":"Unknown","blackBoxWarning":false,"name":"IRON ISOMALTOSIDE 1000","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diafer","Iron isomaltoside 1000","Isofer","Jilazo","Monofer","Monofer (isomaltoside)"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4298047","drugType":"Antibody","blackBoxWarning":false,"name":"TAFASITAMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monjuvi","Monjuvi (tafasitamab-cxix) for injection"],"synonyms":["MOR-00208","MOR00208","MOR208","Mor-208","Mor00208","Tafasitamab","Tafasitamab-cxix","XmAb5574","Xmab-5574","Xmab5574"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000096","MONDO_0001023","EFO_0000095","EFO_0000220","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_0005952"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL4300858","drugType":"Unknown","blackBoxWarning":false,"name":"DOTAMTATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297347"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4446357","canonicalSmiles":"C[C@@]1(O)CCC[C@H]1n1c(=O)c(C(F)F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21","inchiKey":"QIEKHLDZKRQLLN-FOIQADDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBVACICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ebvaciclib","PF-06873600","Pf-06873600"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL449325","canonicalSmiles":"COc1ccc2nc[nH]c2c1","inchiKey":"ILMHAGCURJPNRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL449325","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04130"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594379","canonicalSmiles":"N[C@@H](Cc1ccc(OP(=O)(O)O)c(O)c1)C(=O)O","inchiKey":"YNDMEEULGSTYJT-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSLEVODOPA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-hydroxy-o-phosphono-l-tyrosine","ABBV-951","ABBV-951 COMPONENT FOSLEVODOPA","Foslevodopa","Levodopa-4'-monophosphate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594438","canonicalSmiles":"CC(C)(C#Cc1ccc(-c2ccc(Cl)c3c(NS(C)(=O)=O)nn(CC(F)(F)F)c23)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O","inchiKey":"BRYXUCLEHAUSDY-WEWMWRJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENACAPAVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-6207","GS-714207","GS-CA-2","GS-CA1","GS-CA2","GS-HIV","Lenacapavir"],"childChemblIds":["CHEMBL4802249"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594566","drugType":"Antibody","blackBoxWarning":false,"name":"ONGERICIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JS 002","JS-002","Js002","Ongericimab"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650294","drugType":"Antibody","blackBoxWarning":false,"name":"IMALUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAX-069","BAX-69","BAX69","Imalumab"],"linkedTargets":{"rows":["ENSG00000240972"],"count":1},"linkedDiseases":{"rows":["EFO_1001480"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4650424","drugType":"Protein","blackBoxWarning":false,"name":"SVN53-67/M57-KLH PEPTIDE VACCINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Survaxm","Svn53-67/m57-klh peptide vaccine"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650517","drugType":"Gene","blackBoxWarning":false,"name":"MESMULOGENE ANCOVACIVEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mesmulogene ancovacivec","TG-4010","TG4010","Tg4010"],"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802190","drugType":"Unknown","blackBoxWarning":false,"name":"ASTX-029","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASTX-029","ASTX029","Astx-029","Astx029"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802205","drugType":"Unknown","blackBoxWarning":false,"name":"EOS-884448","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EOS-884448","EOS884448","Eos-884448","Eos884448"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL485253","canonicalSmiles":"CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1","inchiKey":"KPJZHOPZRAFDTN-NQUBZZJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYSERGIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deseril"],"synonyms":["Methysergide"],"crossReferences":{"drugbank":["DB00247"],"chEBI":["584020"]},"childChemblIds":["CHEMBL3989558"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000135914","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962 and is indicated for migraine disorder."}
{"id":"CHEMBL501613","canonicalSmiles":"C#CC(C)(O)CC","inchiKey":"QXLPXWSKPNOQLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPARFYNOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dormison","Oblivon"],"synonyms":["Atemorin","Meparfynol","Methylparafynol","Methylpentynol","NSC-28797"],"crossReferences":{"PubChem":["144205847"],"drugbank":["DB13733"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL502097","canonicalSmiles":"COCCO[C@H]1[C@@H](O)[C@H](COP(=O)([O-])S[C@H]2[C@H](COP(=O)([O-])S[C@H]3[C@H](COP(=O)([O-])S[C@H]4[C@H](COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(N)ncnc76)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5CO)O[C@H](n5cc(C)c(N)nc5=O)[C@H]4OCCOC)O[C@H](n4cnc5c(N)ncnc54)[C@H]3OCCOC)O[C@H](n3cc(C)c(N)nc3=O)[C@H]2OCCOC)O[C@@H]1n1cc(C)c(N)nc1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"OSGPYAHSKOGBFY-KMHHXCEHSA-A","drugType":"Oligonucleotide","blackBoxWarning":true,"name":"MIPOMERSEN SODIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219536","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kynamro"],"synonyms":["ISIS 301012","ISIS-301012","Mipomersen sodium","Mipomersen sodium salt"],"crossReferences":{"DailyMed":["mipomersen%20sodium"],"Wikipedia":["Mipomersen"]},"linkedTargets":{"rows":["ENSG00000084674"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0000319","EFO_0004911"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for cardiovascular disease and familial hypercholesterolemia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL509336","canonicalSmiles":"CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1","inchiKey":"YJQZYXCXBBCEAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACTOPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ractopamine"],"crossReferences":{"PubChem":["26758024"],"Wikipedia":["Ractopamine"],"drugbank":["DB11541"],"chEBI":["82647"]},"childChemblIds":["CHEMBL2105358"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL514315","canonicalSmiles":"CSCC1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)O1","inchiKey":"SRQKTCXJCCHINN-NYYWCZLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURATEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Macmiror","Magmilor","Polmiror","Tydantil"],"synonyms":["Inimur","Methylmercadone","NF-113","Nifuratel","Omnes","SAP-113"],"crossReferences":{"drugbank":["DB13724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL515966","canonicalSmiles":"COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1","inchiKey":"XPNMCDYOYIKVGB-CONSDPRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZLOPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CJ-11, 974","CJ-11,974","Cj-11974","Ezlopitant"],"crossReferences":{"Wikipedia":["Ezlopitant"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL55960","canonicalSmiles":"Cc1cc(/C=C/c2ccccc2)cc(C)c1O","inchiKey":"PAHKYLUYTGBFNW-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL55960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL577711","canonicalSmiles":"CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","inchiKey":"MEOYFIHNRBNEPI-UXIGCNINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2334737","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2334737","LY2334737","Ly-2334737","Ly2334737"],"crossReferences":{"drugbank":["DB12906"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL578","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"GBXSMTUPTTWBMN-XIRDDKMYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRIL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C09AA02","Enalapril","Lexxel","Olinapril","Vaseretic","Vasotec"],"crossReferences":{"DailyMed":["enalapril%20maleate"],"PubChem":["11112847","144204423","170464969","29214998"],"TG-GATEs":["95"],"Wikipedia":["Enalapril"],"drugbank":["DB00584"],"chEBI":["4784"]},"childChemblIds":["CHEMBL1200659"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000756","EFO_0004234","EFO_0000401","EFO_0000318","EFO_1001905","EFO_0005669","EFO_0000373","EFO_0003914","EFO_0008585","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0004289","EFO_0003884","EFO_0004212","EFO_0000280","EFO_0000685","MONDO_0018638","HP_0000093","EFO_0005529","EFO_0000556","EFO_0000222","EFO_0000319","EFO_0004194","EFO_0000537","EFO_0000311","EFO_0003106","HP_0012664","MONDO_0001134","EFO_1001482","MONDO_0100096","MONDO_0005147","EFO_0007328","EFO_0001378","EFO_0000668"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL61872","canonicalSmiles":"CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3","inchiKey":"JACAAXNEHGBPOQ-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GYKI-53773","LY-300164","Talampanel"],"crossReferences":{"Wikipedia":["Talampanel"],"drugbank":["DB04982"],"chEBI":["34992"]},"linkedTargets":{"rows":["ENSG00000120251","ENSG00000155511"],"count":2},"linkedDiseases":{"rows":["EFO_0000630","EFO_0000474","MONDO_0005180","EFO_0002499","EFO_0002501","MONDO_0004976","EFO_0000519","EFO_1000158"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL62807","canonicalSmiles":"C[C@H]1CCCC[C@@H]1Oc1cccc(-c2nc3cc(C(=N)N)c(F)cc3[nH]2)c1O","inchiKey":"CMCDWLMEDRBWIR-GTNSWQLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62807","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6448","canonicalSmiles":"OCCOCOCc1cc(CCCCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1","inchiKey":"JLSNWEWWUSOSMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6448","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08721"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL69998","canonicalSmiles":"CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1","inchiKey":"FULAPETWGIGNMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIROCOXIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Equioxx"],"synonyms":["Firocoxib","Firocoxib (ema epar: veterinary)","Librens","ML-1,785,713","ML-1785713","NSC-758895","Previcox"],"crossReferences":{"Wikipedia":["Firocoxib"],"drugbank":["DB09217"],"chEBI":["76136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7728","canonicalSmiles":"CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O","inchiKey":"UYXAWHWODHRRMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Evipal","Sombucaps","Sombulex"],"synonyms":["Enhexymal","Hexobarbital","Hexobarbital ciii","NSC-71929"],"crossReferences":{"PubChem":["144205214","170465860","26754503","29215369","47194291"],"Wikipedia":["Hexobarbital"],"drugbank":["DB01355"],"chEBI":["5706"]},"childChemblIds":["CHEMBL2104880"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL790","canonicalSmiles":"N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1","inchiKey":"GHXZTYHSJHQHIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Avagard","Chlorhexadine","Chlorhexidine","Dentisept","Exidine","Hibistat","Merfen-incolore"],"crossReferences":{"DailyMed":["chlorhexidine%20gluconate"],"PubChem":["104171271","11112130","124881938","144203876","144208602","144213755","164339372","170464748","17389113","26752881","56324225","56324718","56463343"],"Wikipedia":["Chlorhexidine"],"drugbank":["DB00878"],"chEBI":["3614"]},"childChemblIds":["CHEMBL1330113","CHEMBL1484251","CHEMBL486819","CHEMBL1628","CHEMBL4297088","CHEMBL2106050"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 5 approved and 29 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL93645","canonicalSmiles":"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl","inchiKey":"MNIPYSSQXLZQLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACECLOFENAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gerbin","Preservex"],"synonyms":["Aceclofenac","Aceclofenac betadex"],"crossReferences":{"PubChem":["11112873","144204261","170465979","50085951"],"Wikipedia":["Aceclofenac"],"drugbank":["DB06736"],"chEBI":["31159"]},"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000546","HP_0002829","HP_0003326","EFO_1001139","EFO_0000685","MONDO_0003937","MONDO_0005178","EFO_0005755"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 approved and 1 investigational indication."}
{"id":"CHEMBL938","canonicalSmiles":"CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C","inchiKey":"PFGWGEPQIUAZME-NXSMLHPHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SARALASIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1-sar-8-ala-angiotensin ii","Sar-arg-val-tyr-val-his-pro-ala","Saralasin"],"crossReferences":{"Wikipedia":["Saralasin"],"drugbank":["DB06763"]},"childChemblIds":["CHEMBL1200670"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
